NVDQ up +9.87% percent right now. $NVDQ High is at 15.94 and the Low 14.46 with current volume of 598,100.
Recent News posted below.
NVDQ Novadaq Technologies Recent Headline News
Novadaq misses 3Q profit forecasts
Automated Insights - Thu Nov 06, 5:12PM CST
MISSISSAUGA, Ontario (AP) _ Novadaq Technologies Inc. (NVDQ) on Thursday reported profit of $3 million in its third quarter.
NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ Reports Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 06, 3:03PM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its third quarter ended September 30, 2014. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States ("U.S." dollars.
NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
Novadaq Technologies (NVDQ) Weak On High Volume
at The Street - Mon Nov 03, 9:02AM CST
Trade-Ideas LLC identified Novadaq Technologies (NVDQ) as a weak on high relative volume candidate
NVDQ: 15.92 (+1.43)
Nasdaq stocks posting largest percentage increases
AP - Fri Oct 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
SGMS: 12.39 (+0.32), NDQ.TO: 17.94 (+1.44), GRPN: 7.50 (-0.02), YRCW: 23.97 (+0.86), NVDQ: 15.92 (+1.43), OPLK: 20.63 (-0.22)
NOVADAQ Announces Transfer of SPY(R) Elite Business From LifeCell Corporation
GlobeNewswire - Thu Oct 30, 3:48PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that it and LifeCell(TM) Corporation ("LifeCell", an Acelity company, have agreed to transfer all marketing and distribution rights to the SPY Elite(R) System from LifeCell to NOVADAQ. The transfer will be effective November 30, 2014 (the "Effective Date". LifeCell will provide certain services during a transition period from December 1, 2014 to December 31, 2014 for a service fee equal to the approximate revenue share pursuant to the distribution agreements.
NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ to Participate in November Investor Healthcare Conferences
GlobeNewswire - Mon Oct 27, 3:30PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in three investor conferences in November.
NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ Appoints Mizuho Medical as PINPOINT Distributor for Japan
GlobeNewswire - Tue Oct 21, 3:39PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that it has entered into an exclusive 5-year agreement with Mizuho Medical Corporation for distribution of the PINPOINT(R) Endoscopic Fluorescence Imaging System in Japan.
NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
Profound Medical elects Dr Arun Menawat to board
M2 - Fri Oct 17, 7:13AM CDT
Medical device company Profound Medical revealed on Friday the appointment of Dr Arun Menawat to its board of directors.
NVDQ: 15.92 (+1.43)
NOVADAQ selects Kirloskar Technologies as its exclusive distributor in India
M2 - Fri Oct 17, 7:08AM CDT
Fluorescence imaging company Novadaq Technologies (NasdaqGM:NVDQ) (TSX:NDQ.TO) stated on Thursday that it plans to distribute its groundbreaking fluorescence imaging technologies in India exclusively through India's Kirloskar Technologies Pvt (KTPL).
NVDQ: 15.92 (+1.43)
NOVADAQ to Release Third Quarter 2014 Financial Results on November 6, 2014 -- Conference Call to Follow
GlobeNewswire - Fri Oct 17, 6:30AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or "the Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the third quarter of 2014 after market close on Thursday, November 6, 2014.
NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
Profound Medical Appoints Dr. Arun Menawat to Board of Directors
GlobeNewswire - Fri Oct 17, 6:00AM CDT
Profound Medical Inc., a medical device company developing and commercializing a unique, minimally invasive treatment for prostate cancer, today announced the addition of Dr. Arun Menawat to its Board of Directors.
TEN: 53.31 (-0.69), NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ Appoints Kirloskar Technologies as Its Exclusive Distributor in India
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that it has appointed Kirloskar Technologies Pvt., Ltd. ("KTPL", as the exclusive distributor for the Company's family of fluorescence imaging technologies in India.
NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
5 Stocks Spiking on Unusual Volume
at The Street - Thu Oct 02, 8:15AM CDT
Keep these stocks trading on unusual volume on your radar.
SRPT: 16.12 (-0.14), TRUE: 16.42 (+0.08), TSN: 41.11 (-0.42), NVDQ: 15.92 (+1.43), ADSK: 59.42 (+0.22)
Novadaq PINPOINT Studies Published in JACS and Annals of Surgery
GlobeNewswire - Thu Oct 02, 6:00AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that final results from the PILLAR(TM)II study, Perfusion Assessment in Laparoscopic Left Anterior Resection, were published ahead of print online by the Journal of the American College of Surgeons ("JACS", the official scientific publication of the American College of Surgeons. In addition, results of a trial conducted in patients undergoing esophagectomy with a gastric pull up reconstruction conducted at the University of Southern California, was published ahead of print online by the Annals of Surgery ("Annals".
NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
Novadaq Technologies expands LUNA's commercial footprint through partnership with SerenaGroup
M2 - Wed Oct 01, 6:53AM CDT
Fluorescence imaging company Novadaq Technologies (TSX:NDQ.TO) reported on Tuesday the launch of an agreement to provide its multiple LUNA fluorescence angiography systems to its patients through partnership with SerenaGroup in Cambridge, Massachusetts.
NVDQ: 15.92 (+1.43)
NOVADAQ Announces Multi-Unit Agreement With SerenaGroup for LUNA
GlobeNewswire - Tue Sep 30, 7:30AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that it has entered into a partnership agreement for multiple LUNA(TM) fluorescence angiography systems with SerenaGroup(TM), in Cambridge, Massachusetts. SerenaGroup(TM) operates wound and hyperbaric centers throughout the United States and is a global leader in wound healing research.
NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ to Host Analyst & Investor Day on November 17, 2014
GlobeNewswire - Wed Sep 17, 6:00AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will host an Analyst & Investor Day on Monday, November 17, 2014. The event will be held at the Sofitel Hotel in New York, NY from 10:00 a.m. to 2:30 p.m. ET.
NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ Announces Appointment of Robert S. White to Its Board of Directors
GlobeNewswire - Tue Sep 02, 6:10AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that Robert "Bob" S. White has been appointed to the Company's Board of Directors.
MDT: 68.10 (-0.64), NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
Weakness Seen in Novadaq Technologies (NVDQ) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 7:48AM CDT
Novadaq Technologies has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
ATEC: 1.39 (-0.06), RTIX: 5.09 (+0.02), ERB: 3.12 (+0.02), NVDQ: 15.92 (+1.43)
Recent News posted below.
NVDQ Novadaq Technologies Recent Headline News
Novadaq misses 3Q profit forecasts
Automated Insights - Thu Nov 06, 5:12PM CST
MISSISSAUGA, Ontario (AP) _ Novadaq Technologies Inc. (NVDQ) on Thursday reported profit of $3 million in its third quarter.
NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ Reports Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 06, 3:03PM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its third quarter ended September 30, 2014. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States ("U.S." dollars. NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
Novadaq Technologies (NVDQ) Weak On High Volume
at The Street - Mon Nov 03, 9:02AM CST
Trade-Ideas LLC identified Novadaq Technologies (NVDQ) as a weak on high relative volume candidate
NVDQ: 15.92 (+1.43)
Nasdaq stocks posting largest percentage increases
AP - Fri Oct 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
SGMS: 12.39 (+0.32), NDQ.TO: 17.94 (+1.44), GRPN: 7.50 (-0.02), YRCW: 23.97 (+0.86), NVDQ: 15.92 (+1.43), OPLK: 20.63 (-0.22)
NOVADAQ Announces Transfer of SPY(R) Elite Business From LifeCell Corporation
GlobeNewswire - Thu Oct 30, 3:48PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that it and LifeCell(TM) Corporation ("LifeCell", an Acelity company, have agreed to transfer all marketing and distribution rights to the SPY Elite(R) System from LifeCell to NOVADAQ. The transfer will be effective November 30, 2014 (the "Effective Date". LifeCell will provide certain services during a transition period from December 1, 2014 to December 31, 2014 for a service fee equal to the approximate revenue share pursuant to the distribution agreements. NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ to Participate in November Investor Healthcare Conferences
GlobeNewswire - Mon Oct 27, 3:30PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in three investor conferences in November. NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ Appoints Mizuho Medical as PINPOINT Distributor for Japan
GlobeNewswire - Tue Oct 21, 3:39PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that it has entered into an exclusive 5-year agreement with Mizuho Medical Corporation for distribution of the PINPOINT(R) Endoscopic Fluorescence Imaging System in Japan. NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
Profound Medical elects Dr Arun Menawat to board
M2 - Fri Oct 17, 7:13AM CDT
Medical device company Profound Medical revealed on Friday the appointment of Dr Arun Menawat to its board of directors.
NVDQ: 15.92 (+1.43)
NOVADAQ selects Kirloskar Technologies as its exclusive distributor in India
M2 - Fri Oct 17, 7:08AM CDT
Fluorescence imaging company Novadaq Technologies (NasdaqGM:NVDQ) (TSX:NDQ.TO) stated on Thursday that it plans to distribute its groundbreaking fluorescence imaging technologies in India exclusively through India's Kirloskar Technologies Pvt (KTPL).
NVDQ: 15.92 (+1.43)
NOVADAQ to Release Third Quarter 2014 Financial Results on November 6, 2014 -- Conference Call to Follow
GlobeNewswire - Fri Oct 17, 6:30AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or "the Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the third quarter of 2014 after market close on Thursday, November 6, 2014. NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
Profound Medical Appoints Dr. Arun Menawat to Board of Directors
GlobeNewswire - Fri Oct 17, 6:00AM CDT
Profound Medical Inc., a medical device company developing and commercializing a unique, minimally invasive treatment for prostate cancer, today announced the addition of Dr. Arun Menawat to its Board of Directors.
TEN: 53.31 (-0.69), NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ Appoints Kirloskar Technologies as Its Exclusive Distributor in India
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that it has appointed Kirloskar Technologies Pvt., Ltd. ("KTPL", as the exclusive distributor for the Company's family of fluorescence imaging technologies in India. NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
5 Stocks Spiking on Unusual Volume
at The Street - Thu Oct 02, 8:15AM CDT
Keep these stocks trading on unusual volume on your radar.
SRPT: 16.12 (-0.14), TRUE: 16.42 (+0.08), TSN: 41.11 (-0.42), NVDQ: 15.92 (+1.43), ADSK: 59.42 (+0.22)
Novadaq PINPOINT Studies Published in JACS and Annals of Surgery
GlobeNewswire - Thu Oct 02, 6:00AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that final results from the PILLAR(TM)II study, Perfusion Assessment in Laparoscopic Left Anterior Resection, were published ahead of print online by the Journal of the American College of Surgeons ("JACS", the official scientific publication of the American College of Surgeons. In addition, results of a trial conducted in patients undergoing esophagectomy with a gastric pull up reconstruction conducted at the University of Southern California, was published ahead of print online by the Annals of Surgery ("Annals". NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
Novadaq Technologies expands LUNA's commercial footprint through partnership with SerenaGroup
M2 - Wed Oct 01, 6:53AM CDT
Fluorescence imaging company Novadaq Technologies (TSX:NDQ.TO) reported on Tuesday the launch of an agreement to provide its multiple LUNA fluorescence angiography systems to its patients through partnership with SerenaGroup in Cambridge, Massachusetts.
NVDQ: 15.92 (+1.43)
NOVADAQ Announces Multi-Unit Agreement With SerenaGroup for LUNA
GlobeNewswire - Tue Sep 30, 7:30AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that it has entered into a partnership agreement for multiple LUNA(TM) fluorescence angiography systems with SerenaGroup(TM), in Cambridge, Massachusetts. SerenaGroup(TM) operates wound and hyperbaric centers throughout the United States and is a global leader in wound healing research. NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ to Host Analyst & Investor Day on November 17, 2014
GlobeNewswire - Wed Sep 17, 6:00AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will host an Analyst & Investor Day on Monday, November 17, 2014. The event will be held at the Sofitel Hotel in New York, NY from 10:00 a.m. to 2:30 p.m. ET. NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
NOVADAQ Announces Appointment of Robert S. White to Its Board of Directors
GlobeNewswire - Tue Sep 02, 6:10AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that Robert "Bob" S. White has been appointed to the Company's Board of Directors. MDT: 68.10 (-0.64), NDQ.TO: 17.94 (+1.44), NVDQ: 15.92 (+1.43)
Weakness Seen in Novadaq Technologies (NVDQ) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 7:48AM CDT
Novadaq Technologies has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
ATEC: 1.39 (-0.06), RTIX: 5.09 (+0.02), ERB: 3.12 (+0.02), NVDQ: 15.92 (+1.43)
